QUIDELORTHO CORP Increase (Decrease) in Accounts Payable
QUIDELORTHO CORP (QDEL) reported Increase (Decrease) in Accounts Payable of -$39.00 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-07
- QUIDELORTHO CORP increase (decrease) in accounts payable for the quarter ending 2026-06-28 was -$11.30M.
- QUIDELORTHO CORP increase (decrease) in accounts payable for the quarter ending 2026-03-29 was -$27.70M.
- QUIDELORTHO CORP increase (decrease) in accounts payable for the quarter ending 2025-12-28 was $55.90M.
- QUIDELORTHO CORP increase (decrease) in accounts payable for the quarter ending 2025-09-28 was $7.60M, a 8.57% increase year-over-year.
- QUIDELORTHO CORP increase (decrease) in accounts payable for fiscal 2025 was $40.00M.
- QUIDELORTHO CORP increase (decrease) in accounts payable for fiscal 2024 was -$23.40M, a 880.00% decline from fiscal 2023.
- QUIDELORTHO CORP increase (decrease) in accounts payable for fiscal 2023 was $3.00M, a 87.23% decline from fiscal 2023.
- QUIDELORTHO CORP increase (decrease) in accounts payable for fiscal 2023 was $23.50M, a 125.96% increase from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$11.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$39.00M 10-Q · filed 2026-08-07 | $16.90M derived: sum of 3 quarters · filed 2026-08-07 | $24.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | -$27.70M 10-Q · filed 2026-05-06 | $28.20M derived: sum of 2 quarters · filed 2026-05-06 | $35.80M derived: sum of 3 quarters · filed 2026-05-06 | $13.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $55.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $63.50M derived: sum of 2 quarters · filed 2026-02-19 | $41.30M derived: sum of 3 quarters · filed 2026-08-07 | $40.00M 10-K · filed 2026-02-19 |
| 2025-09-28 | $7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$14.60M derived: sum of 2 quarters · filed 2026-08-07 | -$15.90M 10-Q · filed 2025-11-06 | -$22.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | -$22.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$23.50M 10-Q · filed 2026-08-07 | -$30.00M derived: sum of 3 quarters · filed 2026-08-07 | -$23.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | -$1.30M 10-Q · filed 2026-05-06 | -$7.80M derived: sum of 2 quarters · filed 2026-05-06 | -$800.00K derived: sum of 3 quarters · filed 2026-05-06 | -$14.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | -$6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $500.00K derived: sum of 2 quarters · filed 2026-02-19 | -$12.70M derived: sum of 3 quarters · filed 2026-02-19 | -$23.40M 10-K · filed 2026-02-19 |
| 2024-09-29 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$6.20M derived: sum of 2 quarters · filed 2025-11-06 | -$16.90M 10-Q · filed 2025-11-06 | -$7.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$13.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$23.90M 10-Q · filed 2025-08-06 | -$14.60M derived: sum of 3 quarters · filed 2026-02-19 | $14.10M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$10.70M 10-Q · filed 2025-05-08 | -$1.40M derived: sum of 2 quarters · filed 2026-02-19 | $27.30M derived: sum of 3 quarters · filed 2026-02-19 | $13.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $38.00M derived: sum of 2 quarters · filed 2026-02-19 | $24.40M derived: sum of 3 quarters · filed 2026-02-19 | $3.00M 10-K · filed 2026-02-19 |
| 2023-10-01 | $28.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $15.10M derived: sum of 2 quarters · filed 2024-11-08 | -$6.30M 10-Q · filed 2024-11-08 | $8.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$13.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$35.00M 10-Q · filed 2024-08-01 | -$20.70M derived: sum of 3 quarters · filed 2025-02-27 | $35.30M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | -$21.40M 10-Q · filed 2024-05-09 | -$7.10M derived: sum of 2 quarters · filed 2025-02-27 | $48.90M derived: sum of 3 quarters · filed 2025-02-27 | -$50.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $14.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $70.30M derived: sum of 2 quarters · filed 2025-02-27 | -$29.10M derived: sum of 3 quarters · filed 2025-02-27 | $23.50M 10-K · filed 2025-02-27 |
| 2022-10-02 | $56.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$43.40M derived: sum of 2 quarters · filed 2023-11-02 | $9.20M 10-Q · filed 2023-11-02 | $23.10M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | -$99.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$46.80M 10-Q · filed 2023-08-09 | -$32.90M derived: sum of 3 quarters · filed 2024-08-01 | -$26.30M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $52.60M 10-Q · filed 2023-05-04 | $66.50M derived: sum of 2 quarters · filed 2024-08-01 | $73.10M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $13.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $20.50M derived: sum of 2 quarters · filed 2024-08-01 | $10.40M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | $6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$3.50M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | -$10.10M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $52.20M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |